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Abstract 
Background: To determine the frequency of 
haematoxicity in patients with snake bite.  
Methods:  In this descriptive study patients (n=84) 
with history of snake bite were included. After 
detailed history, patients were assessed for 
spontaneous bleeding along with evaluation of 
laboratory parameters for hematotoxicity. 
Results: Majority (71.4%) were males. Age group 
maximally affected by snake bite was 21-30 years 
(38.1%). Hematotoxicity was seen in 69% patients, 
while neurotoxicity was seen in 3.3% . Deranged PT 
and APTT were the most frequent abnormality(81%), 
followed by hematuria (27.6%) and 
thrombocytopenia (20.7%). Spontaneous bleeding 
from mucocutaneous sites, hematemesis and 
bleeding from venepuncture site were seen in 8.6%, 
8.6% and 5.2% of hematotoxic snake bites 
respectively.  
Conclusion: Snakebite is a major public health 
problem. Hematotoxic snake bites are potentially 
dangerous, and are the most common type of snake 
bites in our setup.   
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Introduction 
           Snake bite is a serious global health problem. It 
causes significant morbidity and mortality as 
venomous snakes are native throughout the world. It 
has been estimated that 5 million snake bite cases 
occur worldwide every year, causing about 100,000 
deaths.1 It is estimated that each year 4 million persons 
are bitten in Asia alone, half of the bites being 
venomous. For Africa and Latin America about 1.000 
deaths may occur in each area annually.2-4 Pakistan 
has an estimated 20,000 snakebite deaths each 
year.5The incidence of snake bite in developing 
countries however is underestimated because most 
victims prefer to go to traditional healers rather than 
seeking treatment at hospitals.6-8 
     On an average - cobras and sea snakes result in 
about 10% mortality ranging from 5-15 hours 
following bite. Vipers have a more variable mortality 
rate of 1-15% and generally more delayed (up to 48 
hours). While there are many factors influencing the 
outcome in victims of snake-bite, there is significantly 
higher mortality among victims who have delayed 
presentation and develop neurotoxicity.9Not all bites 
by poisonous snakes are venomous.11  Most snake bites 
occur during the monsoon season because of flooding 
of the habitat of snakes. Incidence also varies with 
farming activity in relation to rainfall, as it increases 
the chances of exposure to snake, and to the yearly 
reproductive cycle of the snake. Epidemics of snake 
bite have occurred in Pakistan, India and Colombia 
due to severe flooding.11,12 Male predominance, higher 
incidence in field areas, involvement of lower 
extremities are common features in many studies.13-16  
     Most snake bites occur on the feet and ankles of 
agricultural workers, snake handlers and hunters. For 
these people, envenomation is an occupational hazard. 
Snakes do not generally attack human beings 
unprovoked. Bites mostly happen when the snake is 
trodden on in darkness or unintentionally picked up 
along with foliage. Intentional handling or trying to 
play with snake also results in bite.  At night snake 
may enter the house in search of prey (mice, lizards 
etc) and bite the person sleeping on the floor.17 Snake 
venoms are not single toxins but cocktail of many 
components: enzymes, non enzymatic compounds, 
non-toxic proteins, metals, carbohydrates, lipids, free 
aminoacids, nucleotides and biogenic amines. The 
venom composition varies from species to species and 
is the basis of the clinical diversity of ophitoxaemia. 
Ophitoxaemia leads to increase in the capillary 
permeability which may cause loss of blood and 
plasma volume into the extravascular space leading to 
edema and may be severe enough to compromise 
circulation. The venom may also have direct 
neurotoxic action leading to paralysis and respiratory 
arrest, cardiotoxic effect causing cardiac arrest, 
myotoxic and nephrotoxic effect.18   
Patients and Methods  
          This descriptive study was conducted at Medical 
Emergency Departments of Benazir Bhutto Hospital 
and District Headquarters Hospital. The duration of 
study was six months i.e. from 02.07.2009 to 
01.01.2010. Patients (n=84) with history of snake bite 
were included in the study. Patients with history of 
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bleeding diathesis, patients receiving anti coagulants 
and those with chronic liver disease (history of liver 
disease for >6 months and evidence of chronic liver 
disease on abdominal ultrasound) were excluded from 
the study.Patients were observed by naked eye for 
spontaneous bleeding from mucocutaneous sites, 
bleeding from venepuncture sites and hematemesis 
(vomiting of blood: bright or coffee ground) as 
evidence of hematotoxicity. Hematotoxicity was 
measured in form of presence of thrombocytopenia on 
blood complete picture, hematuria and deranged 
coagulation profile (PT/APTT). Urine microscopy was 
done for presence of hematuria. All patients showing 
signs and symptoms of toxicity were treated with anti 
snake venom according to standard protocols. 
 
Results 
    A total of 84 cases of snake bite (14-70 years of age) 
were enrolled. Majority (71.4%) were male.Mean age 
of patients was 33.06 years (SD ±14.58).  Age group 
that was maximally affected by snake bite was 
between 21-30 years (Table 1).Hematotoxicity was 
seen in 69%,where as neurotoxicity was seen in 3.3%  
(Table 2&3). 
Table 1. Haematotoxicity according to gender 
Haematotoxity Gender of patient 
Total  Male Female 
Yes   
No (%) 
No(%) 
40 (66.7) 18(75.0) 58(69.0) 
No 
No(%) 
No(%) 
20 (33.3) 6(25.0) 26(31.0) 
Total No(%) 60 (100) 24(100) 84 (100) 
Table 2. Comparison of venomous and non 
venomous  snake bites. 
  Total snakebites 100% (84 patients) 
Venomous Non Venomous 
71.4% (n=60) 
28.6% (n=24) Hematoxic Neurotoxic 
96.7%(n=58)  3.3% (n=2) 
    Deranged PT and APTT were the most frequent 
abnormality, each seen in 47 patients (81%) with 
hematotoxicity, followed by hematuria (27.6%, n=16) 
and thrombocytopenia (n=12, 20.7%).Mean PT was 
30.83 ±15.89 sec and mean APTT was 50.88 sec (SD 
±20.24). Spontaneous bleeding from mucocutaneous 
sites was  seen in 8.6% (Table 3).Ptosis was seen in 
neurotoxic snake bites. All 84 cases were hospitalized. 
Patients who did not show signs and symptoms of 
toxicity were discharged after 24 hours of 
hospitalization, whereas ASV was administered to all 
cases of venomous snake bite according to the hospital 
protocol. 
Table 3: Snakebite induced toxicity-Clinico-
haematological profile 
Variable No (%) 
Haematoxicity (n=58) 
Deranged PT/APTT 47(81) 
Thrombocytopenia 12(20.7) 
Haematuria 16(27.6) 
Spontaneous bleeding from 
mucocutaneous sites 
5(8.6) 
Haematemsis 5(8.6) 
Bleeding from vene- puncture site  3(5.2) 
Neurotoxicity (n=2) 
Ptosis 2 (100%) 
Opthalmoplegia 2 (100%) 
Respiratory muscle weakness  2(100%) 
 
Discussion 
      Snake bite is a global problem, especially of rural 
communities living in the tropics, where basic health 
facilities are poor and as a result deaths are common. 
The true burden of snake bite is not known due to 
under and misreporting. South Asia is the world's 
most heavily affected region, due to its high 
population density, widespread agricultural activities, 
numerous venomous snake species and lack of 
functional snake bite control programs.19 
     Snake venom, the most complex of all poisons, is a 
mixture of enzymatic and non-enzymatic compounds 
as well as other non-toxic proteins, carbohydrates and 
metals. The variation of venom composition from 
species to species explains the clinical diversity of 
ophitoxaemia. Venomous snake bites can present with 
local or systemic features of envenoming - 
haematotoxicities, neurological symptoms, 
myotoxicities, organ failure and some nonspecific 
features. In some cases victims present with 
complication of treatment by traditional healers or self 
induced inappropriate application of tourniquet.20 
     Studies show that young age group is a more 
vulnerable section of the population for snake bite.21 
Gender distribution is almost uniform in literature 
with males being affected twice or thrice as commonly 
as females. As  males are more commonly involved in 
outdoor activities, this might explain why they fall 
prey to snakes more frequently.22,23  
     There may be predominance of a type of toxicity 
seen in a population in certain geographical area of the 
world. This can be attributed to the species of snakes 
found in that particular area. In a descriptive case 
series in Amritsar (India), Singh et al. reported that all 
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of the envenomations were neurotoxic.24 Sheikh et al. 
found primarily hematotoxic manifestations of 
snakebite in majority.25 Hematotoxicity was seen in a 
large number (69%) of patients in our study, making it 
a predominant manifestation.Not all snake bites result 
in systemic envenomation.  In our study a total of 
71.4% of snake bite victims showed signs and 
symptoms of toxicity, of which 96.7% of venomous 
bites were hematotoxic bites and only two cases of 
neurotoxic bites (ptosis, ophthalmoplegia, respiratory 
muscle weakness) were seen. Rest of snake bites were 
unable to produce any toxic manifestations in victims 
i.e. they were dry bites. This observation is consistent 
with the studies done earlier in both of these 
hospitals.26   
     Venoms such as Russell’s viper venom contain 
enzymes that have a procoagulant effect in vitro; while 
in vivo there is an anticoagulant effect. This is because 
these enzymes activate different steps of the clotting 
cascade. A purified enzyme can influence several 
coagulation factors simultaneously. Most of this is 
immediately broken down by the body’s own 
fibrinolytic system. Eventually the levels of clotting 
factors become so depleted that the blood will not clot. 
This is called consumption coagulopathy. Sufficient 
quantities of neutralizing antivenom should be 
administered before making attempts to correct a 
coagulopathy.27  
     In an Iranian study  hematuria was seen in 68% of 
victims where as in our study, the frequency was 
27.6% in those showing hematotoxic manifestations. It 
can be ascribed to an increased number of 
rhabdomyolysis, myoglobinuria and hemoglobinuria, 
in Iranian study. These parameters can lead to 
increased risk of renal damage which in turn leads to 
hematuria.28 Thrombocytopenia and platelet 
dysfunction is commonly seen in snake bites. It can be 
due to different proteins which can destroy and also 
can protein functional platelets impairment.29,30 
 
Conclusion 
In our set up hematotoxic snake bites and are 
potentially dangerous and are most common type of 
bite 
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